CD40 agonist

This page covers all CD40 agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD40.

Targets

CD40

Phase 3 pipeline (1)

• C21 · Vicore Pharma AB · Oncology
  C21 is a CD40 agonist that activates the CD40 receptor on immune cells to enhance anti-tumor immune responses.